Many Patients With Advanced MCC Not Receiving Immunotherapy

Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.

Related Keywords

New York ,United States ,Phoenix ,Arizona ,Philadelphia ,Pennsylvania ,Fox Chase Cancer Center ,Jeffrey Farma ,Shayan Cheraghlou ,Department Of Surgical Oncology ,National Cancer Database ,American College Of Mohs Surgery ,Drug Administration ,Grossman School Of Medicine ,American College ,Mohs Surgery ,Surgical Oncology ,Biologic Therapy ,Iologics ,Skin Cancer ,Alignant Skin Neoplasm ,Immunotherapy ,Merkel Cell Carcinoma ,Merkel Cell Cancer ,Rabecular Cancer ,Pudoma Of Skin ,Mall Cell Neuroepithelial Tumor Of The Skin Small Tumour ,Dcc ,Merkel Cell Carcinoma Mcc ,Cc Merkel Cell Carcinoma ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Clinical Guidelines ,